TabsDetailsBasic DetailsDate Posted: Tuesday, March 27, 2018Status: CompleteMedical Product: carbidopa/levodopa, carbidopa/levodopa/entacapone (Stalevo), entacaponeDescription: This report investigates acute myocardial infarction (AMI) and stroke among users of entacapone, combination carbidopa/levodopa, and combination carbidopa/levodopa/entacapone (Stalevo) with Parkinson’s Disease in the Mini-Sentinel Distributed Database (MSDD). The package was distributed to Partners on February 24, 2011. Read More Deliverables (1)Mini-Sentinel Modular Program Report: Risk of Acute Myocardial Infarction and Stroke among Carbidopa/Levodopa, Entacapone, and Carbidopa/Levodopa/Entacapone UsersAdditional InformationAdditional DetailsFDA Center: CDERTime Period: January 1, 2000 - December 31, 2010Study Type: Modular ProgramAssessment Type: Exploratory AnalysesPopulation / Cohort: All individuals with Parkinson's DIseaseData Sources: Mini-Sentinel Distributed Database (MSDD)
